Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 21, 2012; 18(31): 4191-4198
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4191
Published online Aug 21, 2012. doi: 10.3748/wjg.v18.i31.4191
Variable | Overall survival | Disease-free survival | Cancer-specific survival | |||
P value | HR (95% CI) | P value | HR (95% CI) | P value | HR (95% CI) | |
BMI group | 0.000 | 0.002 | 0.369 | |||
Underweight vs normal | 0.000 | 1.58 (1.23-2.05) | 0.002 | 1.49 (1.16-1.93) | 0.107 | 1.33 (0.94-1.87) |
Overweight vs normal | 0.060 | 0.83 (0.68-1.01) | 0.123 | 0.86 (0.71-1.04) | 0.751 | 0.96 (0.76-1.22) |
Obese vs normal | 0.578 | 0.94 (0.74-1.18) | 0.972 | 1.00 (0.79-1.25) | 0.677 | 1.06 (0.80-1.41) |
TNM stage | 0.000 | 0.000 | 0.000 | |||
II vs I | 0.721 | 1.06 (0.77-1.45) | 0.981 | 1.00 (0.74-1.35) | 0.025 | 1.78 (1.07-2.95) |
III vs I | 0.000 | 1.90 (1.39-2.60) | 0.000 | 1.80 (1.34-2.42) | 0.000 | 3.94 (2.39-6.48) |
Age group (yr) | 0.000 | 0.000 | 0.876 | |||
41-75 vs ≤ 40 | 0.054 | 1.45 (0.99-2.11) | 0.052 | 1.44 (0.99-2.09) | 0.672 | 1.09 (0.74-1.58) |
> 75 vs ≤ 40 | 0.000 | 3.14 (2.11-4.67) | 0.000 | 2.88 (1.94-4.25) | 0.607 | 1.12 (0.72-1.74) |
Gender (male vs female) | 0.329 | 1.08 (0.92-1.27) | 0.220 | 1.10 (0.94-1.29) | 0.734 | 1.03 (0.85-1.26) |
Medical illness (comorbidity) | 0.003 | 0.003 | 0.769 | |||
One or two kinds vs none | 0.358 | 1.09 (0.91-1.32) | 0.442 | 1.08 (0.89-1.29) | 0.927 | 0.99 (0.79-1.24) |
> two kinds vs none | 0.001 | 1.40 (1.16-1.71) | 0.001 | 1.39 (1.15-1.68) | 0.478 | 0.91 (0.70-1.18) |
CEA (> 5 vs ≤ 5 ng/mL) | 0.000 | 1.86 (1.58-2.18) | 0.000 | 1.93 (1.65-2.25) | 0.000 | 2.15 (1.77-2.61) |
Hemoglobin (< 10 vs≥ 10 g/dL) | 0.913 | 1.01 (0.84-1.22) | 0.760 | 1.03 (0.86-1.23) | 0.835 | 1.03 (0.81-1.29) |
Albumin (normal vs hypoalbuminemia) | 0.000 | 0.65 (0.54-0.79) | 0.000 | 0.68 (0.57-0.83) | 0.297 | 0.87 (0.67-1.13) |
Operation timing (emergent vs elective) | 0.562 | 1.21 (0.64-2.26) | 0.416 | 1.28 (0.70-2.34) | 0.687 | 1.18 (0.53-2.66) |
Morbidity (yes vs no) | 0.000 | 1.55 (1.26-1.91) | 0.000 | 1.50 (1.23-1.84) | 0.279 | 1.17 (0.88-1.56) |
Tumor location (left vs right) | 0.785 | 1.03 (0.86-1.22) | 0.666 | 1.04 (0.88-1.23) | 0.583 | 1.06 (0.86-1.32) |
Histologic type | 0.079 | 0.144 | 0.055 | |||
Signet ring cell vs adenocarcinoma | 0.039 | 2.19 (1.04-4.63) | 0.065 | 2.03 (0.96-4.30) | 0.017 | 2.68 (1.19-6.01) |
Mucinous vs adenocarcinoma | 0.323 | 1.14 (0.88-1.49) | 0.465 | 1.10 (0.85-1.43) | 0.690 | 1.07 (0.77-1.48) |
Histologic grade (differentiation) | 0.282 | 0.213 | 0.173 | |||
Moderate vs high | 0.363 | 1.11 (0.89-1.37) | 0.143 | 1.17 (0.95-1.45) | 0.061 | 1.32 (0.99-1.76) |
Low vs high | 0.114 | 1.34 (0.93-1.94) | 0.121 | 1.33 (0.93-1.92) | 0.403 | 1.24 (0.75-2.04) |
- Citation: Chin CC, Kuo YH, Yeh CY, Chen JS, Tang R, Changchien CR, Wang JY, Huang WS. Role of body mass index in colon cancer patients in Taiwan. World J Gastroenterol 2012; 18(31): 4191-4198
- URL: https://www.wjgnet.com/1007-9327/full/v18/i31/4191.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i31.4191